Real-Time Real Talk by Dexcom

About Real-Time Real Talk by Dexcom

Enhancing diabetes care with real-time continuous glucose monitoring (CGM) is the focus of GlucoseTech, the go-to podcast for healthcare professionals in the U.S. Whether you're an endocrinologist, primary care physician, diabetes educator, or pharmacist, this show provides expert insights and real-world applications to help you optimize patient outcomes with CGM technology. Each month, GlucoseTech brings you in-depth conversations with leading clinicians, researchers, and industry experts, diving into: How to integrate real-time CGM into your practice - Learn best practices for onboarding patients and interpreting CGM data The latest clinical evidence - Explore groundbreaking studies on real-time CGM and its impact on glucose tracking real-world success stories - hear firsthand experiences from healthcare providers and patients using Dexcom G7 and Stelo to manage type 1 diabetes, type 2 diabetes and prediabetes. Episode topics have included: Type 2 Diabetes Management Through Glucose Tracking: How CGM Improves Patient Outcomes with Dr. Thomas Grace and Dr. William Polonsky Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes with Emily Cornelius, Registered Dietitian Empowering Diabetes Care: Revolutionizing Hospital Discharge Planning with CGM Technology with David Tulle. GlucoseTech is your trusted source for staying up to date on CGM advancements. Hosted by Cher Pastore (MS, RD, CDCES, BC-ADM), she is a registered dietitian and certified diabetes care and education specialist, holding a Master of Science in Nutrition from New York University and a Bachelor of Arts in Psychology from University of Massachusetts Boston. She is also a Director of clinical education at Dexcom. Prior to joining Dexcom, Cher was in clinical practice for more than 10 years, specializing in diabetes technology. While in practice, she developed a love of using CGM as a tool in diabetes care. Cher has been featured in such publications as People, D-Life, Everyday Health, and Diabetes Daily, and has appeared in broadcasts on SiriusXM, Extra TV, Channel 5, Channel 7 News. Now, she's excited to share her expertise on a medical podcast. Dexcom is a leader in real-time CGM technology, empowering patients and healthcare providers with accurate, real-time glucose insights. Dexcom has won more than 20 awards over the last 2 years including: 2025 CES Innovation Award Honoree 2023 Healthcare Marketing Impact Award - Film/TV/Video Campaign of the Year ◦ Dexcom Super Bowl Commercial with Nick Jonas and everyday ‘warriors’ 2024 German Design Award – Dexcom G7 CGM System Learn more at glucosetech.com. Want to get involved with the show? You can reach us at Cher.pastore@dexcom.com to: Bring Dexcom to your event Be a guest on the show Ask Cher a question If you like Diabetes Core Update, Juicebox Podcast: Type 1 Diabetes, The Huddle: Conversations with the Diabetes Care Team, you’ll enjoy this GlucoseTech podcast.

Publisher

Dexcom

Category

education · health & fitness

Language

en

Explicit

No

First episode

19 Oct 2022

Latest episode

6 Oct 2026

Latest episodes

37 episodes in the feed.

1. 

   6 Oct 2026

   Dexcom CEO Jake Leach on Continuous Glucose Monitoring (CGM) Innovation, the CONNECT Study and What’s Next for Glucose Monitoring at ADA 2026

   Exploring innovations that make continuous glucose monitoring (CGM) easier to use, transforming diabetes management for healthcare providers (HCPs) and patients. Dexcom President and CEO Jake Leach explains how advances including G7 15 Day, Smart Basal, Smart Bolus, and EHR integration are helping clinicians optimize diabetes treatment. Live from ADA 2026, he discusses the CONNECT Study, CGM-guided nutrition, and how real-time glucose insights can support people with type 1 diabetes, type 2 diabetes, and prediabetes. -- Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. “Dexcom" refers to the Dexcom CGM. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. The Dexcom G7Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy. G7 15 Day is only for adults 18+. This guest is a paid spokesperson for Dexcom. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2026 Dexcom, Inc. All rights reserved. STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency. BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at CGM Safety Information | Dexcom | Dexcom and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

2. 

   1 Sept 2026

   How Continuous Glucose Monitoring (CGM) Is Helping Healthcare Providers Save Time and Improve Diabetes Treatment

   Pediatric endocrinologist Dr. Anita Swamy interviews host [Host Name] about integrating continuous glucose monitoring into practice to save time and improve diabetes treatment.

3. 

   4 Aug 2026

   How the Connect Trial is proving CGM works for type 2 diabetes patients not on insulin

   Host Cher Pastore interviews Keri Leone, from Dexcom Medical Affairs, about the CONNECT Trial's impact on CGM use for type 2 diabetes patients not on insulin.

Who has been a guest on Real-Time Real Talk by Dexcom

Names identified in recent episode analyses. Showing up to five guests.

• Dr Anita Swamy
• Keri Leone
• Dr Tom Grace
• Dr Bill Polonsky
• Emily Cornelius

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

4.3 / 5

10 ratings

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 16 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

6

Social presence

0

YouTube

0

Engagement

67

Shows with a similar audience

• 

  The Metabolic Classroom

• 

  The Daily

• 

  The Mel Robbins Podcast

• 

  Huberman Lab

• 

  Ajenda by Dr Jen Ashton

• 

  Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives